PTC Therapeutics Inc (PTCT) Insider Trading

Total insider buys:
  • $31,673,582.00
Total insider sells:
  • $173,198,187.08
Most recent insider trade:
  • Feb. 18, 2026
Most active insider trader:
  • Mark Elliott Boulding
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 18, 2026EVP2,484$69.36Sell$172,290.24
Feb. 18, 2026CEO7,371$69.36Sell$511,252.56
Feb. 18, 2026Insider3,056$69.36Sell$211,964.16
Feb. 18, 2026CAO2,494$69.36Sell$172,983.84
Feb. 18, 2026VP3,081$69.36Sell$213,698.16
Feb. 18, 2026CFO2,992$69.36Sell$207,525.12
Feb. 18, 2026Insider3,019$69.36Sell$209,397.84
Feb. 17, 2026VP2,813$69.29Sell$194,912.77
Sept. 12, 2025VP24,585$61.34Sell$1,508,043.90
Sept. 11, 2025Director15,705$59.50Sell$934,447.50
Sept. 11, 2025VP22,664$61.00Sell$1,382,504.00
Sept. 9, 2025Director12,000$58.34Sell$700,080.00
Sept. 8, 2025Insider39,850$56.92Sell$2,268,262.00
Aug. 28, 2025Director1,667$50.15Sell$83,600.05
Aug. 5, 2025CEO10,739$51.74Sell$555,635.86
July 15, 2025CFO2,516$49.46Sell$124,441.36
May 16, 2025VP883$46.02Sell$40,635.66
May 15, 2025VP1,929$46.18Sell$89,081.22
April 22, 2025CEO2,804$48.74Sell$136,666.96
April 2, 2025EVP897$46.95Sell$42,114.15
March 13, 2025Director5,000$54.00Sell$270,000.00
March 12, 2025VP15,521$53.30Sell$827,269.30
March 4, 2025Director1,230$51.52Sell$63,369.60
Feb. 19, 2025EVP795$50.10Sell$39,829.50
Feb. 19, 2025CFO1,168$50.10Sell$58,516.80
Feb. 19, 2025VP1,333$50.10Sell$66,783.30
Feb. 19, 2025CEO1,378$50.10Sell$69,037.80
Feb. 19, 2025CAO879$50.10Sell$44,037.90
Feb. 19, 2025Insider1,300$50.10Sell$65,130.00
Jan. 7, 2025Insider1,265$45.34Sell$57,355.10
Jan. 7, 2025EVP810$45.34Sell$36,725.40
Jan. 7, 2025VP1,543$45.34Sell$69,959.62
Jan. 7, 2025CEO1,599$45.34Sell$72,498.66
Jan. 7, 2025CAO1,291$45.34Sell$58,533.94
Dec. 31, 2024CEO8,279$45.16Sell$373,879.64
Dec. 2, 2024Insider69,550$52.06Sell$3,620,773.00
Dec. 2, 2024VP85,600$52.26Sell$4,473,456.00
Dec. 2, 2024CAO17,800$51.77Sell$921,506.00
Dec. 2, 2024Director24,000$51.50Sell$1,236,000.00
July 16, 2024CFO2,269$34.02Sell$77,191.38
May 22, 2024Director20,000$38.24Sell$764,800.00
May 7, 2024EVP175$32.82Sell$5,743.50
April 19, 2024CEO3,361$24.89Sell$83,655.29
April 17, 2024CEO787$25.14Sell$19,785.18
April 2, 2024EVP526$28.37Sell$14,922.62
Jan. 30, 2024Insider618$27.25Sell$16,840.50
Jan. 30, 2024CAO318$27.25Sell$8,665.50
Jan. 30, 2024VP794$27.25Sell$21,636.50
Jan. 22, 2024Director10,000$27.38Sell$273,800.00
Jan. 8, 2024Insider1,569$28.64Sell$44,936.16
First«1 of 5»Last
  • Insiders are both buying and selling PTC Therapeutics Inc stock.

  • The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, David P Southwell, Claudia De Oliveira Ri Hirawat, Lee Scott Golden, Pierre Gravier, Marcio Souza, Stephanie Okey, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda

  • The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 33 trades.

  • Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.

  • Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.

  • The most recent insider trade for PTC Therapeutics Inc was on Feb. 18, 2026.

  • The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.

  • The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.